PCVX
(NASDAQ)Vaxcyte, Inc.
$55.64-- (--)
Loading... - Market loading
Vaxcyte (PCVX) Stock Price & Financial Analysis
Vaxcyte Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$54.98 - $56.61
52-Week High$65.00
52-Week Low$29.08
Open$55.17
Volume750.33K
Average Volume (3M)1.62M
Market Cap7.76B
Shares Outstanding139.51M
Price to Book (P/B)2.59
EV/EBITDA-7.77
50-Day MA$52.62
200-Day MA$51.68
52-Week Change52.61%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$54.98 - $56.61
52-Week High$65.00
52-Week Low$29.08
Open$55.17
Volume750.33K
Average Volume (3M)1.62M
Market Cap7.76B
Shares Outstanding139.51M
Price to Book (P/B)2.59
EV/EBITDA-7.77
50-Day MA$52.62
200-Day MA$51.68
52-Week Change52.61%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About Vaxcyte
What is the current stock price for PCVX?
As of the latest trading session, PCVX stock trades at $55.64. The 52-week range is $29.08–$65.00, with a day range of $54.98–$56.61.
What is the P/E ratio for PCVX?
The P/E ratio (Price-to-Earnings) for PCVX is shown in the Key Statistics section. This valuation metric helps compare Vaxcyte, Inc. to industry peers.
Does PCVX pay dividends?
Vaxcyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for PCVX?
Based on 6 analysts, the consensus for PCVX is Buy.
What is the market cap of PCVX?
Vaxcyte's market capitalization is $7.76B, classifying it as a mid-cap company. Vaxcyte operates in the Healthcare sector within the Biotechnology industry.